NVP-BSK805 2HCl

CAS No. ——

NVP-BSK805 2HCl ( —— )

Catalog No. M17712 CAS No. ——

NVP-BSK805 2HCl(IC50=0.5 nM), a specific and effective ATP-competitive JAK2 inhibitor, is more than 20-fold specificity over JAK1, JAK3 and TYK2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 176 Get Quote
10MG 241 Get Quote
25MG 446 Get Quote
50MG 630 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NVP-BSK805 2HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    NVP-BSK805 2HCl(IC50=0.5 nM), a specific and effective ATP-competitive JAK2 inhibitor, is more than 20-fold specificity over JAK1, JAK3 and TYK2.
  • Description
    NVP-BSK805 2HCl(IC50=0.5 nM), a specific and effective ATP-competitive JAK2 inhibitor, is more than 20-fold specificity over JAK1, JAK3 and TYK2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    JAK1| JAK2| JAK3| Tyk2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    563.47
  • Molecular Formula
    C27H28F2N6O·2HCl
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1CNCCC1n1cc(cn1)c1nc2c(cccc2nc1)c1cc(c(c(c1)F)CN1CCOCC1)F.Cl.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Baffert F, et al. Mol Cancer Ther, 2010, 9(7), 1945-1955.
molnova catalog
related products
  • Resminostat hydrochl...

    A potent inhibitor of HDAC1/3/6 with IC50s of 43-72 nM; induces hyperacetylation of histone H4 and apoptosis in MM cell lines (IC50=2.5-3 uM).

  • RGFP 966

    RGFP966 is an HDAC3 inhibitor with IC50 of 0.08 μM in cell-free assay, exhibits > 200-fold selectivity over other HDAC.

  • Phenylethyl isothioc...

    Phenylethyl isothiocyanate is an HDAC inhibitor. It potentially for the treatment of benign prostatic hypertrophy.